Estrogen receptor (ER)-positive progesterone receptor (PR)-negative (ER+/PR−) breast cancers are a subset of Luminal B tumors characterized by the strong and diffuse nuclear expression of ER-alpha but not of PR [1]. This evidence concerns the gene PGR and breast carcinoma.